Facts and figures
Placed initially on 4 November 2005 under the former company Biotec Pharmacon, ArcticZymes Technologies ASA is listed on the Oslo Stock Exchange. Being a global leader in development and commercialization of enzymes, we are working continuously on innovative, novel solutions and technologies. Our success stories is not only reflected in our current business figures but also the latest developments on the stock market. Take a look for yourself!
Reports and Finances
Get an insight into our current business developments with our quarterly reports.
Take a look at the current stock market price and our 20 largest shareholders.
Take a deep dive into our business figures from the last few years.
More financial information
|28 Jan 2021||Presentation of the fourth quarter report 2020 and the preliminary annual accounts 2020|
|27 Apr 2021||Annual report 2020|
|22 Apr 2021||Presentation of the first quarter 2021|
|20 May 2021||Annual General Meeting|
|19 Aug 2021||Presentation of the second quarter 2021|
|28 Oct 2021||Presentation of the third quarter 2021|